The X-Factor: Global Impact of Women in the Awareness and Management of Coronary Artery Disease
Heart disease is the #1 killer of women and a major contributor to morbidity and disability. This statement cannot be repeated enough and is often neglected. In 2008, there were 9,127,416 cardiovascular deaths in women worldwide, accounting for 33.2 % of all deaths in women. Coronary artery disease (CAD) differs in symptom presentation, diagnosis, treatment, and outcomes in women compared to men. We have made great strides in diagnosing and managing cardiovascular disease (CVD) in women. However, this progress continues to be overshadowed by the improvements made on the understanding and management of CVD in men.
KeywordsCoronary artery disease CAD Cardiovascular disease CVD Women in cardiology
Compliance with Ethics Guidelines
Conflict of Interest
Divya Gupta, Jennifer Mieres, Leslee Shaw and Sharonne N. Hayes have no relevant disclosures to report. Nanette Wenger has received research grants and contracts and worked on a trial steering committee/trial data safety and monitoring board for Gilead Science, NHLBI, Pfizer, and Society for Women’s Health Research.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by the author.
- 1.https://http://www.acc.org/membership/sections-and-councils/women-in-cardiology-section. Women in Cardiology Section. 2015.
- 2.Coronary Heart Disease in Women. In: Eaker ED PB, Wenger NK, et al., editor Proceedings of an NIH Workshop. New York: Haymarket Doyma Inc, 1987.Google Scholar
- 6.Convention hwwineunseF. NCD Alliance—NCDs: a priority for women’s health and development; global status report on noncommunicable diseases, 2010. World Health Organization.Google Scholar
- 10.http://www.WomenHeart.org. WomenHeart.
- 11.https://http://www.nhlbi.nih.gov/files/docs/heart/whhw.pdf. Women’s Heart Health Education Strategy Development Workshop 2001.